Article Listing - R P SCHERER TO CREATE NEW DIVISION

STOCK MARKET COMMENTARY: EUROPE

13 April 1992

EUROPE: seemed to be impacted in many areas by elections of one sort or another. Despite earlier worries, FRANKFURT seemed...

PHARMA ECONOMICS' "SEVEN DEADLY SINS"

13 April 1992

Concerns about economic evaluation of new drug products have been likened to the seven deadly sins by Michael Drummond of...

SAFER TRAVELLER'S DIARRHEA DRUG

13 April 1992

A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...

US RESISTANCE TO DRUG PRICE RISES

13 April 1992

The US pharmaceutical industry will continue to face growing resistance from the federal government and also from private forces towards...

PROMISING ALZHEIMER'S PROGRAM FROM ATHENA

13 April 1992

In the current explosion of neurology research and development, the US company, Athena Neurosciences, is considered to be one of...

EXPANSION AT SILESIA IN CHILE

13 April 1992

The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...

EPO AND HISTAMINE

13 April 1992

Recombinant erythropoietin therapy lowers plasma histamine concentrations in patients with uremia and can result in marked improvement of pruritus, according...

ROCHE'S LAZABEMIDE IN PHASE III NEXT YEAR

13 April 1992

Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...

ROCHE'S LOCERYL LAUNCHED IN FRANCE

13 April 1992

Roche Produits, a subsidiary of Hoffmann-La Roche, has introduced its nail lacquer antifungal product Loceryl (amorolfine). This is the first...

Showing 94371-94380 of 95356 articles